NEW YORK (GenomeWeb News) – Strategic Diagnostics said today that it has signed an agreement to supply reagents to “a large manufacturer of in vitro diagnostics.”
 
The term of the agreement is five years, and the company said that it expects initial revenues of around $1 million per year, which are anticipated to “more than double” over the term of the agreement.
 
Strategic Diagnostics said it will begin shipping the reagents to the undisclosed client in the fourth quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.